Recently convalescent plasma transfusion (CPT) has been suggested to be an effective treatment of COVID-19 as the donor’s plasma contained specific IgG and IgM anti–SARS-CoV-2 antibodies that can neutralize the virus [104,105]. This evidence concerns the gene CD40LG and COVID-19.